Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 0.910-0.910 for the period, compared to the consensus estimate of 1.040. The company issued revenue guidance of $14.5 billion-$14.5 billion, compared to the consensus revenue estimate of $13.4 billion.
Daiichi Sankyo Stock Up 2.7%
Daiichi Sankyo stock traded up $0.45 during mid-day trading on Monday, reaching $16.96. The stock had a trading volume of 34,187 shares, compared to its average volume of 444,348. The firm has a market capitalization of $32.13 billion, a PE ratio of 15.56, a price-to-earnings-growth ratio of 0.85 and a beta of -0.25. Daiichi Sankyo has a fifty-two week low of $15.56 and a fifty-two week high of $28.21. The stock’s 50-day simple moving average is $17.94 and its 200-day simple moving average is $20.47. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.85 and a current ratio of 2.69.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded shares of Daiichi Sankyo from a “strong sell” rating to a “hold” rating in a research note on Tuesday, May 5th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, Daiichi Sankyo currently has an average rating of “Buy”.
Daiichi Sankyo Company Profile
Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody?drug conjugates in its development programs.
Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.
Featured Articles
- Five stocks we like better than Daiichi Sankyo
- 3 Metals and Mining Stocks Riding the Commodity Supercycle
- Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?
- The Stars Are Aligning For Apple: Get Ready for $300
- 3 Small-Cap Stocks to Buy as the Russell 2000 Extends Its Rally
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
